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Open access under CC BYBackground: The aim of this study was to develop an original method to extract sets of relevant molecular
biomarkers (gene sequences) that can be used for class prediction and can be included as prognostic and
predictive tools.
Materials and methods: The method is based on sequential patterns used as features for class prediction.
We applied it to classify breast cancer tumors according to their histological grade.
Results: We obtained very good recall and precision for grades 1 and 3 tumors, but, like other authors, our
results were less satisfactory for grade 2 tumors.
Conclusions: We demonstrated the interest of sequential patterns for class prediction of microarrays and
we now have the material to use them for prognostic and predictive applications.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
Breast cancer is a major public health issue today. According to
the breastcancer.org,1 with 192,370 new cases in 2009 in the US,
breast cancer is the most frequently diagnosed malignancy and
the main cause of cancer death in women. One out of eight women
will develop breast cancer during her lifetime. New treatments are
continually being developed to target speciﬁc types of cancer and
to reduce potentially adverse effects (cardiac dysfunction, prema-
ture menopause, etc.). However, despite early detection and new
treatments, up to 50% of the women will develop distant metasta-
ses, which are unfortunately incurable today. The three major chal-
lenges associated with breast cancer are: (1) How to diagnose
breast cancer as early as possible through population screening
and to identify the type of tumor detected? (2) How to predict
the response of a patient to a given treatment according to classes
of individuals? (3) How to choose the best therapy for a given sub-
ject with an accurate prognosis including her chances of remission,
by deducing from the usual course of the disease its future devel-
opment and its outcome?
DNA microarrays are powerful tools to draw a genetic portrait
of a biological sample (e.g., a tumor sample) by comparing gene
expression in different tissues, cells, and conditions, and providing
information on the relative levels of expression of thousands of5506 – CC 477, 161 rue Ada,
585.
-NC-ND license. genes among samples. These technologies carry with them the
hope of bringing new insights to cancer biology and improving cur-
rent tools for cancer management. Simon and Dobbin [1] describe
three ways of using DNA microarrays:
 Class comparison consists in identifying variations (e.g., in the
expression of the genes) among n classes. It can be used to com-
pare normal tissues and tumors [2], and tumors that respond to
therapy and those that do not [3], or to distinguish various sub-
types of a tumor [4,5]. Class comparison enables identiﬁcation
of the critical role of certain genes by establishing the molecular
identity of a class, like a bar code. This code can then be used for
class prediction.
 Class discovery consists in discovering new subgroups in a
population (e.g., subtypes of a tumor) based on the molecular
proﬁle. For example, Sotiriou et al. [5] describe subtypes of
breast cancer.
 Class prediction uses the results of the previous process to assign
a new specimen (a new microarray) to a known class, e.g. to a
subtype of a tumor [6]. If the classiﬁer is conﬁdent, the result
can be used by medical experts to make clinical decisions
(e.g., for population screening) to predict the effects of a treat-
ment for a patient or for prognoses.
The objective of this study was to develop an original method to
extract sets of relevantmolecular biomarkers (gene sequences) that
can be used for class prediction and as a prognostic and predictive
tool. Molecular biomarkers are generated from analyses of DNA
microarrays and are based on a particular data mining technique:
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rithm to extract these frequent patterns of correlated genes ordered
according to their level of expression.Anexampleof suchapattern is
h(17aagovcadn)(tgzadipup,rettdn)i, 80%Gr1, 40%Gr2meaning that ‘‘For
80% of Grade 1 tumors, and 40% of Grade 2 tumors, the level of
expression of gene 17aagovcadn is lower than that of tgzadipup and
rettdn, whose levels of expression are very close’’. Sequential pat-
terns have already been used successfully for text categorization.
In this paper,we investigate the relevanceof suchpatterns for tumor
classiﬁcation. The complexity of the data and the interdisciplinary
context make this task extremely challenging.
Our contribution is described in terms of methodology, biolog-
ical ﬁndings and medical implications. After brieﬂy presenting the
state of the art (Section 2), we describe the complete methodology
in detail in the material and methods (Section 3). We apply this
methodology to the study of breast cancer (Section 4). To conclude,
we discuss how this methodology can be generalized (Section 5)
according to the kind of data and the data mining approach.Table 1
Gene expressions for microarray M1 and two associated data sequences with a
minimal gap of 0.1.
Microarray G1 G2 G3 G4 G5
M1 6.76 6.65 6.65 9.65 6.75
Associated sequences h(G2G3G5)(G1)(G4)i
h(G2G3)(G5G1)(G4)i2. Background
Due to the amount of data available, processing DNA micro-
arrays in a way that makes biomedical sense is still a major issue.
Statistical methods and data mining techniques play a key role in
discovering previously unknown knowledge. However, their
implementation in this context is difﬁcult because the number of
measurement points (gene expression levels) is much higher than
the number of samples, which results in the well-known problem
of the curse of dimensionality, also called the high feature-to-sample
ratio [4]. Moreover, the correlation structure of the expressions is
unknown (gene co-expressions) and the presence of noise is a seri-
ous problem. For all these reasons, classiﬁcation based on micro-
array data is quite different from previous classiﬁcations and
traditional methods are not successful [8].
Most studies are based on the search for differentially expressed
genes, particularly disease-speciﬁc genes. These methods work like
a ﬁlter and reduce the size of the group of genes in the experiment
to a smaller one, which can be more easily investigated. Most
widely used methods use univariate procedures often combined
with adjustment of P-values or a similar concept [9,10]. SAM [10]
or CyberT [11] are well-known programs based on such tech-
niques. Unlike multivariate approaches such as ANOVA, these
methods do not take into account the multidimensional structure
of the data [12]. We could also cite other approaches based on
combinations of various artiﬁcial intelligence techniques [13,7].
However, several authors [14,9] have compared most of these
methods and shown that they do not necessarily detect the same
subset of differentially expressed genes.
Nevertheless, the above-mentioned methods do help rank the
genes for the development of biomarkers that can be used for class
discovery. Differentially expressed genes are features used to dis-
criminate subgroups of specimens. Many diseases are heteroge-
neous and characterized by the presence of several subgroups.
This is the case of breast cancer [15]. The discovery of associations
between prognostic information and responses to therapy and the
molecular signatures that characterize subgroups has greatly facil-
itated the development of treatments tailored to speciﬁc sub-
groups. To discover the subgroups concerned, we focus on the
case where the experiments monitor the gene expression of differ-
ent tissue samples, and the aim is to ﬁnd a structure in this collec-
tion of unlabeled data to associate with a category, describing, for
example, a subgroup of tumors. Several authors [16,15,5] have
published such lists concerning breast cancer.
Once the subgroups are deﬁned, it is possible to associate a new
microarray with a class with class prediction by comparing a newspecimen to features describing the subgroups. Several authors
[17,18,16,19] have proposed successful methods but it is still too
difﬁcult to use them to improve breast cancer prognosis or predic-
tion [20]. The pitfalls have been emphasized by many authors
[21,1], these include the risk of over-ﬁtting due to the high fea-
ture-to-sample ratio and the lack of validation due to the absence
of independent datasets or the incorrect use of cross-validation
techniques. Although the number of measured genes is in the thou-
sands, it is assumed that only a few genes determine the type of a
tissue. More recent studies focus on ﬁnding such groups of genes.
In this paper, we do not try to ﬁnd the minimum subsets of genes
but look for gene sequences that we can use as features for the pre-
diction of different classes.
3. Material and methods
The class prediction system involves two steps: Step 1 – Building
the classiﬁer: (1) The sequence preprocessing module transforms
the raw data into gene sequences; (2) The feature selection module
extracts sequential patterns, which have a close relationship with a
given type of class; Step 2 – Evaluation of the classiﬁer: The classiﬁ-
cation module makes decisions concerning categories of testing
samples and examines whether the classiﬁcation results are conﬁ-
dent or not.
Details of the methods used in each module are described in
Sections 3.1, 3.2 and 3.3.
3.1. Sequence preprocessing module
For each microarray, we have a list of genes associated with an
expression value (see Table 1). The aim of this step is to build se-
quences by ordering the genes according to their value. In classical
database vocabulary, the genes are called items. An itemset iti is a
non-ordered group of genes with similar expression. By consider-
ing the gaps between the expression of the genes (see Table 1),
G2 and G3 are grouped in the same itemset because they have
the same expression, but considering a minimal gap equal to 0.1,
G5 can be either grouped in it1 = (G2G3G5) or in it2 = (G1G5).
A sequence S = hitaitb. . .itpi is a non-empty and ordered list of p
itemsets, i.e. groups of genes ordered according to their expression.
From a microarray, we generate as many sequences as there are
possible itemsets. Table 2 gives associated data sequences with a
minimal gap of 0.1.
3.2. Feature selection module
Table 2 gives an example of data used as input in the feature
selection module.
The aim of this step is to build sequential patterns [22], in our
case frequent sequences of genes, to characterize a class. A pattern
is supported by a microarray if the pattern is included in one or
more sequences associated with a microarray. For example (see Ta-
ble 2), the pattern P = h(G2)(G5)i is included in one of the two M1
data sequences. So, P is supported by the microarray class1. The
support of a pattern P in a class classi, denoted by supportclassi ðPÞ,
is deﬁned as the percentage of microarrays that support P in that
Table 2
Gene sequences for ﬁve microarrays and two classes. The microarrays M1, M2 and M5
are associated with the class 1 and M3 and M4 are associated with the class 2.
According to a minimal gap, two sequences are associated with the microarray M1
and M5 and one sequence is associated with the microarrays M2, M3 and M4.
Microarray Class Associated genes sequences
M1 1 h(G2 G3G5)(G1)(G4)i
h(G2 G3)(G5 G1)(G4)i
M2 1 h(G1)(G4)(G2)(G3)(G5)i
M5 1 h(G2G5)(G4)(G3)(G1)i
h(G2)(G5 G4)(G3)(G1)i
M3 2 h(G1)(G4)(G5)(G2)(G3)i
M4 2 h(G1)(G2)(G3)(G4)(G5)i
Table 5
Scores by class associated with sequence S. According to the distribution in Table 4,
the sequence S is included in zero pattern of class 1, in two patterns of class 2 and in
one pattern of class 3.
Sequence Class
1
Class
2
Class
3
S = h(G1)(G2G3)(G4)(G5G6)(G7)(G8)(G9)(G10G11)i 0 2 1
Table 6
Example of results obtained after cross-validation. Precision = 15/20, Recall = 15/18
and F-measure = 2(15/2015/18)/(15/20+15/18).
Class Number of sequences
Associated with the class Correctly labeled Labelled
1 20 15 18
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obtain the most frequent patterns, a minimum support is provided
and the patterns extracted must have a support greater this thresh-
old, called the minimum support. For instance, if the minimum
support is equal to 2/3, P is frequent in class1 but not in class2.
These deﬁnitions were given in a previous work [4], and an efﬁ-
cient algorithm was developed. In this paper, we have adapted
the PreﬁxSpan algorithm [23] to take into account n sequences
associated with a microarray. [24] have shown that Preﬁxspan is
pseudo-polynomial. The complexity is O((2N) ^ L) where N is the
number of items and L is the maximum length of the initial gene
sequences of the microarrays.
For class prediction, we only look for relevant patterns and not
for all patterns. We rank the patterns to keep only the k best pat-
terns for each class according to a measure based on the support
value. For each pattern, the ranking measure is the difference be-
tween their two highest supports. For example (see Table 3), the
gap between the two highest supports for pattern P1 is 0.4 and
for P2, 0.5. Consequently, pattern P2 has a better rank than pattern
P1. The interest of these patterns is that they can be used to distin-
guish classes but they also enable to take into account additional
information with respect to differentially expressed genes, i.e.
the order of expression of correlated gene groups.3.3. Classiﬁcation module
The objective is to assign S = h(G1)(G2G3)(G4)(G5G6)(G7)(G8)
(G9)(G10G11)i an unlabeled sequence to a class (a category of
tumor). We compare S to n% of the ranking patterns by class. Con-
sider the patterns P1, P2, P3 (see Table 4), with P1, P3 for class2,
and P2 for class3. When S contains a pattern, the score of S for the
class associated with the pattern is increased by 1. Table 5 givesTable 3
Gaps obtained for two patterns for three classes. For each pattern, support has been
computed for each class. For a particular, the best gap is equal to the difference
between the two highest supports. In this example P2 ‘‘is better’’ than P1 because P2
has the highest best gap.
Patterns Supports in the different classes Best gap
Class 1 Class 2 Class 3
P1 0.4 0.8 0.1 0.4
P2 0.1 0.7 0.2 0.5
Table 4
Distribution of the sequential patterns in three classes. As P1 and P3 have the highest
support in Class 2, they are associated with Class 2. P2 is associated with Class 3.
Patterns Class 1 Class 2 Class 3
P1 = h(G1)(G2G3)(G4)i 0.2 0.8 0.1
P2 = h(G5G6)(G7)(G8)i 0.1 0.0 0.9
P3 = h(G9)(G10G11)i 0.3 0.7 0.1the score of S for each class. As the highest score is for class2, S is as-
signed to class2.
To evaluate the classiﬁcation, we measure the precision and the
recall for each class. Precision is the number of sequences correctly
assigned to a class divided by the total number of sequences as-
signed to this class (correctly or not). The recall is the number of
sequences correctly assigned to a class, divided by the number of
sequences of real data belonging to this class. Table 6 gives an
example of such a calculation. An F-measure combines Precision
and Recall according to Formula 1:
F ¼ 2  precision  recall
precisionþ recall ð1Þ4. Experiments
Datasets and objectives: We examined the following microarray
datasets: a dataset provided by the IRCM which is not public, and
datasets available online from Gene Expression Omnibus2 KJX64-
KJ125 (GSE2990), TAM (GSE6532), and TBG2 (GSE7390), focusing
on a total of 624 human Affymetrix microarrays HG 133. All these
microarrays share 22,000 probesets.3 To start the study, we focused
on a subset of this list, the 128 genes identiﬁed by Sotiriou et al. [5]
for breast cancer. Below, we illustrate the power of classiﬁcation
based on sequential patterns in the case of breast cancer through
one question: how to classify a new microarray according to its his-
tological grade [25,26]? This grade is a well-known variable with
three values. It is used in clinical studies for its high prognostic po-
tential in breast cancer. For example, patients with a grade 1 tumor
have better survival rates than those with a grade 3 tumor. The dis-
tribution of the microarrays is 162 for grades 1, 274 for 2 and 185 for
3.
Extraction of sequential patterns: The extraction parameters are
deﬁned experimentally. As shown in Fig. 1, in this type of data, it
is difﬁcult to extract patterns with a minimum support in a reason-
able timeframe (we only keep patterns with a support greater than
a given threshold named minimum support). We do not look for all
patterns but only for a subset of patterns enabling efﬁcient classi-
ﬁcation. For rapid extraction, we split the gene base into few
groups and extract patterns from each. We experimentally vary
the number of genes and the support. We observed that the most
accurate approach is to form groups of 42 genes that can be ex-
tracted in 350 s with a miniuml support of 0.4.
In Fig. 2, we gradually increase the number n of microarrays
used for the extraction. For each n, we randomly select n micro-2 http://www.ncbi.nlm.nih.gov/geo/.
3 Even though it is misusing the language, we use the term gene for probeset.
Fig. 1. Extraction time vs. minimal support.
Fig. 2. Stability of the generation of the patterns.
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the number of common patterns. The higher the n, the more ex-
tracted patterns are the same. Experimentally, we ﬁxed n at 80
per grade to get a consistent training set and to keep enough
microarrays to be able to validate the classiﬁer in the validation
set.
Classiﬁcation: We used a cross-validation process to assess how
the results of our classiﬁer are generalized to an independent data-
set. One round of cross-validation involves distributing the data
into complementary subsets, building the classiﬁer on the training
set, and validating the analysis on the validation set. According to
the results deduced from Fig. 2, we extracted sequential patterns
on 80 specimens (38% of the total base) and validated the classiﬁer
on the remaining specimens (62%). To reduce variability, multiple
rounds (50) were performed using different distributions. We used
the 100 best sequential patterns for each grade.
Table 7 shows the evaluation of the method for the three
grades. The method remains valid for more than three classes.
We obtained optimistic results for grades 1 and 3 (Recall) and
bad results for grade 2. These results are consistent with [5] whoTable 7
Evaluation of the classiﬁer per grade. For a total of 104 genes (68 involved in
sequences associated with Class 1, 57 with Class 2 and 55 with Class 3), we obtain
various measures of Recall, Precision and F-measure by class.
Grade 1 Grade 2 Grade 3
Recall .81 .15 .86
Precision .39 .76 .54
F-measure .53 .25 .66
Involved genes 68 57 55
Total genes 104found that breast cancers of grades 1 and 3 had distinct gene
expression proﬁles that appear in the patterns, but that grade 2
had heterogeneous gene expression proﬁles that are not captured
by the patterns. In most cases, the specimens are wrongly classiﬁed
in grade 1 or 3 (Precision). The line 4 of Table 7 corresponds to the
genes used in the patterns that describe a grade. The last line gives
the union between the genes involved in each grade. It should be
noted that the genes are not the same for each grade. The genes
can be ranked according to their efﬁciency for class prediction
thank to the number of patterns in which they appear and all genes
used to construct the pattern can be reduced considering the best
genes.
By considering only grades 1 and 3, and the three grades (Table
8), we compared our classiﬁer with those of Weka software that re-
fer to the data mining community. We calculated the recall, the
precision and the F-measure for each group of classiﬁers. Consider-
ing only grades 1 and 3 or only grade 3, we obtained the higher
F-measure with the IRCM dataset in all cases. The results were
least satisfactory when considering the combination of IRCM and
online datasets or online datasets alone.
We can make two assumptions: (1) the online datasets are het-
erogeneous and it is more difﬁcult to obtain relevant sequential
patterns: the microarrays were obtained from patients undergoing
different treatments, with different types of tumor and many oth-
ers parameters that affect gene expression. (2) Our classiﬁer is
more effective for an imbalanced dataset. Unsatisfactory results
were obtained for grade 2 tumors (Table 7) with all the datasets,
but optimist results with the IRCM dataset. From a list of patterns,
we can effectively classify tumors into grades. Unlike a list of dif-
ferentially expressed genes speciﬁc to a class, the patterns can be
used to compare different classes and thus provide answers to
different questions concerning prognosis. We can take into account
Table 8
Classiﬁer evaluation. Family of classiﬁers available in Weka are compared to our method in the last line entitled SP in term of Recal, Precision and F-measure. We vary the number
of class (Grades 1 and 3/Grades 1, 2 and 3) and the datasets (IRCM, IRCM and online datasets alone). The highest F-measure scores are in bold in this table.
Classiﬁer Grades 1 and 3 Grades 1, 2 and 3
IRCM IRCM and online datasets Online datasets IRCM
R P F R P F R P F R P F
Rules (9) 0.954 0.967 0.959 0.922 0.922 0.922 0.924 0.906 0.915 0.715 0.706 0.710
Bayes (8) 0.921 0.932 0.926 0.819 0.826 0.822 0.920 0.918 0.819 0.702 0.716 0.708
Functions (5) 0.955 0.970 0.962 0.902 0.901 0.902 0.917 0.918 0.917 0.760 0.802 0.779
Lazy (4) 0.909 0.939 0.923 0.922 0.931 0.926 0.937 0.943 0.940 0.727 0.721 0.724
Misc (3) 0.934 0.942 0.937 0.937 0.934 0.936 0.932 0.936 0.934 0.736 0.714 0.724
Tree (12) 0.928 0.944 0.936 0.943 0.944 0.944 0.938 0.943 0.940 0.765 0.770 0.767
SP 0.962 0.974 0.968 0.896 0.910 0.903 0.891 0.880 0.885 0.769 0.797 0.782
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textual information to produce a bar code (list of patterns) from
a limited set of genes (one hundred). A category could be: a grade
2 tumor, between 2 and 3 cm, treated with hormones, etc. Once a
patient is classiﬁed in a category, we can use the information about
the future of the patient already assigned to a class to predict her
resistance to the various therapies or to make a prognosis for each
choice of therapy.
5. Conclusions and prospects
In this paper, we focus on the classiﬁcation of DNA microarrays
based on sequential patterns. Our contribution is two-fold: (i) we
have developed a classiﬁcation technique based on sequential pat-
terns and not on differentially expressed genes, which is the case of
most of the methods cited in the literature; (ii) we checked it
experimentally to verify the interest of these features for the clas-
siﬁcation of tumors according to their histological grade. We have
shown that the method is effective at highlighting biological differ-
ences between grades 1 and 3 tumors and is better than other clas-
siﬁers when the datasets are imbalanced. Like the other methods,
the classiﬁcation is not efﬁcient for grade 2 tumors. We hope to im-
prove these results by using another form of distribution described
by Sotiriou et al. [5]. We try now to improve the patterns extrac-
tion module to manage more genes. We can also go a step further
and use this technique for prediction and prognosis.
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